Avadel Pharmaceuticals PLC Cash Flow Quality Index

Latest as of September 2025: 1162.99x

Avadel Pharmaceuticals PLC cash flow quality index. Avadel Pharmaceuticals PLC (AVDL) has a Cash Flow Quality Index of 1162.99x as of September 2025. Operating cash flow of $23.26 Million exceeds net income of $20.00K, indicating high earnings quality where cash backs reported profits. Explore AVDL operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

1162.99x
Operating CF / Net Income

Operating Cash Flow

$23.26 Million
USD

Net Income

$20.00K
USD

Data as of

Sep 2025
Most recent filing

Cash Flow Quality Index of Avadel Pharmaceuticals PLC (2002–2020)

Cash flow quality index of Avadel Pharmaceuticals PLC from 2002 to 2020. Historical Cash Flow Quality Index for Avadel Pharmaceuticals PLC across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. See Avadel Pharmaceuticals PLC (AVDL) net asset quality to measure how much of total assets are equity-financed.

Avadel Pharmaceuticals PLC Cash Flow Quality Index by Year (2002–2020)

Avadel Pharmaceuticals PLC cash flow quality index by year from 2002 to 2020. Year-by-year earnings quality comparison for Avadel Pharmaceuticals PLC. For the full cash flow conversion analysis, see cash efficiency ratio of Avadel Pharmaceuticals PLC.

Year Quality Index Operating CF (USD) Net Income YoY Change
2020 -6.93x $-48.73 Million $7.03 Million ▼ -2898.9%
2017 0.25x $16.66 Million $67.25 Million ▼ -88.0%
2015 2.07x $84.29 Million $40.66 Million ▲ +724.4%
2004 -0.33x $-4.15 Million $12.50 Million ▼ -111.4%
2002 2.92x $8.77 Million $3.00 Million —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.